Abstracts tagged "Human papillomavirus (HPV) and systemic lupus erythematosus (SLE)"

Abstract Number: 792 • 2015 ACR/ARHP Annual Meeting
Incidence and Persistence of Cervical Human Papillomavirus Infection in Mexican Systemic Lupus Erythematosus Women
Claudia Mendoza Pinto¹, Mario García-Carrasco^2,3, Verónica Vallejo-Ruiz⁴, Socorro Méndez-Martínez⁵, Alejandro Taboada-Cole⁶, José Luis Totolhua Ramírez⁷, Julio Reyes-Leyva⁴ and Aurelio López-Colombo⁸, ¹Systemic Autoimmune Diseases Research Unit, HGR 36-CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Mexico, ²Systemic Autoimmune Diseases Research Unit, HGR 36-CIBIOR Instituto Mexicano del Seguro Social, Puebla, Mexico, ³Inmunología y Reumatología, Universidad Autónoma de Puebla, Puebla, Mexico, ⁴Molecular Biology and Virology Laboratory, CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Mexico, ⁵Research Coordination Delegation, Instituto Mexicano del Seguro Social, Puebla, Mexico, ⁶Systemic Autoimmune Disease Research Unit, HGR 36, Instituto Mexicano del Seguro Social, Puebla, Mexico, ⁷Department of Pathology, HGR 36, Instituto Mexicano del Seguro Social, Puebla, Mexico, ⁸State Research and Education Department, UMAE,Hospital de Especialidades, Instituto Mexicano del Seguro Social, Puebla, Mexico
Background/Purpose: The risk of high-grade squamous intraepithelial lesions is significantly increased in SLE patients compared with healthy female controls. High-risk human papillomavirus infection (HR-HPV) is…
Abstract Number: 620 • 2013 ACR/ARHP Annual Meeting
Human Papillomavirus and Precancerous Lesions In Patients With Systemic Lupus Erythematosus
Eleonora Lucero¹, Laura Juarez¹, Veronica Bellomio¹, Francisco Colombres², Maximiliano Machado Escobar¹, Raúl Nicolás Martínez¹, Teresita Alvarellos³, Agustina Lacaze³, Ariel Sanchez⁴, Pablo Agustín Apas Perez de Nucci⁵, Guillermo Cohen Imach⁵, Sonia Marcela Ortiz Mayor⁶, Iris Aybar Odstrcil⁶, Ana Cerón⁶, Ricardo V. Juárez⁷, Mirta Santana⁸ and Alberto Berman¹, ¹Rheumatology Unit, Padilla Hospital, Tucumán, Argentina, ²Centro Medico Privado de Reumatologia, Tucumán, Argentina, ³Biological Molecular Laboratory, Córdoba Private Hospital, Córdoba, Argentina, ⁴Biological Molecular Unit, Córdoba Private Hospital, Córdoba, Argentina, ⁵Ginecology Unit, Padilla Hospital, Tucumán, Argentina, ⁶Pathology Unit, Padilla Hospital, Tucumán, Argentina, ⁷Rheumatology Section, Hospital Señor del Milagro, Salta, Argentina, ⁸Padilla Hospital, Tucumán, Argentina
Background/Purpose: To evaluate the presence of Precancerous Lesions (PL) in uterine cervix in patients with Systemic Lupus Erythematosus (SLE) and its relationship with Human Papillomavirus…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].